Okrodin (Octreotide)

Octreotide, the active ingredient in Okrodin, is a peptide synthetic analog of somatostatin presented as a sterile solution for subcutaneous injection use. It regulates hormone secretion and is employed in the management of hormone‑secreting tumors and related complications.

GNH USA supplies Okrodin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Okrodin is a somatostatin analogue that modulates neuro‑endocrine pathways involved in several endocrine disorders.

- Acromegaly: reduces excess growth hormone levels and improves associated symptoms. - Carcinoid syndrome: controls flushing and diarrhoea associated with serotonin‑secreting tumours. - VIPoma and other functional neuroendocrine tumours: alleviates severe watery diarrhoea and electrolyte imbalance. - Post‑operative post‑operative post‑operative post l  ​  

Side effects of